[HTML][HTML] Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up

R Comune, A Ruggiero, A Portarapillo, A Villani… - Cancers, 2024 - mdpi.com
Simple Summary Cutaneous squamous cell carcinoma is among the most frequent
cutaneous tumors. Over the years, the understanding and diagnostic sensitivity has …

Management approaches for high-risk cutaneous squamous cell carcinoma with perineural invasion: an updated review

M Catalano, F Nozzoli, F De Logu, R Nassini… - … Treatment Options in …, 2024 - Springer
Opinion Statement Cutaneous squamous cell carcinoma (cSCC) stands as the second most
prevalent non-melanoma skin cancer worldwide, comprising approximately 20% of all …

[HTML][HTML] Ex vivo confocal microscopy speeds up surgical margin control of re-excised skin tumors and greatly shortens in-hospital stay

FF Gellrich, J Laske, J Steininger, N Eberl, F Meier… - Cancers, 2024 - mdpi.com
Simple Summary This research explored a new method to evaluate surgical margins when
removing non-melanoma skin cancer, aiming to reduce the time patients need to stay in the …

Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: A systematic review and …

PN Lacerda, EP Lange, NM Luna… - Journal of the …, 2024 - Wiley Online Library
The standard of care for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)
involves excision by conventional surgery (CS) with a predefined safety margin of resection …

Updates in the management of advanced nonmelanoma skin cancer

F Yan, CE Schmalbach - Surgical Oncology Clinics, 2024 - surgonc.theclinics.com
Nonmelanoma skin cancer (NMSC) is a heterogeneous category of cutaneous cancers, with
basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and Merkel cell …

Impact of the COVID-19 Pandemic on the Surgical Management of Head and Neck Non-Melanoma Skin Cancers in a Maxillofacial Center of Cluj-Napoca

RC Roman, CI Faur, E Gordan… - Journal of Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Background: The COVID-19 era has been a bleak period for both cancer and non-cancer
patients, with delayed non-emergency treatments, such as for non-melanoma skin cancer …

[HTML][HTML] Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer

L Winter, J Ries, C Vogl, L Trumet, CI Geppert, R Lutz… - Cells, 2024 - mdpi.com
The establishment of immunotherapy applying immune checkpoint inhibitors (ICI) has
provided an important new option for the treatment of solid malignant diseases. However …

From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments

Z Li, F Lu, F Zhou, D Song, L Chang, W Liu… - Frontiers in …, 2025 - frontiersin.org
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma
skin cancer, among which 82% arise from actinic keratosis (AK) characterized by lesions of …

[HTML][HTML] The Role of Gene Expression Profiling in the Management of Cutaneous Squamous Cell Cancer: A Review

RA Durgham, J Badders, SA Nguyen, L Olinde, J Pang… - Cancers, 2024 - mdpi.com
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin
cancer, with an increasing global incidence. While most cases are successfully treated with …

[HTML][HTML] Evidence of Neutrophils and Neutrophil Extracellular Traps in Human NMSC with Regard to Clinical Risk Factors, Ulceration and CD8+ T Cell Infiltrate

LMH Moeller, C Weishaupt, F Schedel - International Journal of …, 2024 - mdpi.com
Non-melanoma skin cancers (NMSC), including basal cell carcinoma (BCC), cutaneous
squamous cell carcinoma (cSCC), and Merkel cell carcinoma (MCC), are increasingly …